Neuroform EZ
Device
Stryker Corporation
Total Payments
$837,493
Transactions
231
Doctors
77
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2017 | $837,493 | 231 | 77 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $705,768 | 100 | 84.3% |
| Consulting Fee | $124,058 | 24 | 14.8% |
| Food and Beverage | $3,482 | 90 | 0.4% |
| Travel and Lodging | $3,461 | 16 | 0.4% |
| Space rental or facility fees (teaching hospital only) | $725.00 | 1 | 0.1% |
Payments by Type
Research
$705,768
100 transactions
General
$131,725
131 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| ATLAS | Stryker Corporation | $361,207 | 0 |
| Thromboembolic Performance of the Neuroform Stent in Internal Carotid Artery Aneurysm Treatment (Neuroform Study) | Stryker Corporation | $90,945 | 0 |
| Atlas Study | Stryker Corporation | $90,840 | 1 |
| ATLAS IDE | Stryker Corporation | $32,000 | 0 |
| Atlas Trial | Stryker Corporation | $30,593 | 0 |
| ATLAS Trial | Stryker Corporation | $28,369 | 0 |
| HDE Neuroform | Stryker Corporation | $24,320 | 0 |
| ATLAS Study | Stryker Corporation | $20,083 | 0 |
| Atlas Sudy | Stryker Corporation | $10,600 | 0 |
| HDE Neuroform & Wingspan WIRM Fees 2016 2017 | Stryker Corporation | $4,470 | 0 |
| HDE Nueroform | Stryker Corporation | $4,455 | 0 |
| Neuroform Microdelivery Stent System | Stryker Corporation | $2,900 | 0 |
| HDE Neuroform Renewal Fees | Stryker Corporation | $2,000 | 0 |
| The Neuroform Microdelivery Stent | Stryker Corporation | $1,515 | 0 |
| HDE Neuroform IRB Fees | Stryker Corporation | $1,470 | 0 |
Top Doctors Receiving Payments for Neuroform EZ
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | San Francisco, CA | $705,793 | 100 |
| , MD | Neurological Surgery | Pittsburgh, PA | $45,159 | 16 |
| , MD | Neurological Surgery | Miami, FL | $23,700 | 2 |
| , DO | Vascular Neurology | Harlingen, TX | $12,235 | 3 |
| , MD | Diagnostic Radiology | Winston Salem, NC | $12,161 | 3 |
| , MD | Vascular Neurology | Toledo, OH | $10,248 | 8 |
| , MD | Neurological Surgery | Baltimore, MD | $7,853 | 5 |
| , M.D | Neurological Surgery | Los Angeles, CA | $6,379 | 2 |
| , M.D | Student in an Organized Health Care Education/Training Program | Palm Springs, CA | $3,805 | 3 |
| , M.D., MS | Neurological Surgery | San Diego, CA | $2,000 | 1 |
| , M.D | Neurology | Nashville, TN | $1,700 | 2 |
| , M.D | Neuroradiology | Stanford, CA | $700.00 | 1 |
| , M.D., PH.D | Neuroradiology | San Francisco, CA | $700.00 | 1 |
| , M.D | Neurology | Milwaukee, WI | $525.00 | 1 |
| , M.D | Vascular & Interventional Radiology | San Francisco, CA | $500.00 | 1 |
| , MD | Neurology | San Francisco, CA | $425.00 | 1 |
| , M.D | Neurological Surgery | New York, NY | $400.00 | 1 |
| , MD, PHD | Neurological Surgery | Buffalo, NY | $212.50 | 1 |
| , M.D | Vascular & Interventional Radiology | Houston, TX | $175.77 | 2 |
| , M.D | Diagnostic Radiology | Houston, TX | $175.77 | 2 |
| , M.D | Neuroradiology | Morgantown, WV | $166.55 | 2 |
| , M.D., PH.D | Diagnostic Radiology | Orange, CA | $128.97 | 3 |
| , M.D | Diagnostic Radiology | Knoxville, TN | $123.87 | 1 |
| , MD | Neurology | Pittsburgh, PA | $106.30 | 2 |
| , MD | Neurological Surgery | Charlotte, NC | $104.65 | 1 |
Ad
Manufacturing Companies
- Stryker Corporation $837,493
Product Information
- Type Device
- Total Payments $837,493
- Total Doctors 77
- Transactions 231
About Neuroform EZ
Neuroform EZ is a device associated with $837,493 in payments to 77 healthcare providers, recorded across 231 transactions in the CMS Open Payments database. The primary manufacturer is Stryker Corporation.
Payment data is available from 2017 to 2017. In 2017, $837,493 was paid across 231 transactions to 77 doctors.
The most common payment nature for Neuroform EZ is "Unspecified" ($705,768, 84.3% of total).
Neuroform EZ is associated with 15 research studies, including "ATLAS" ($361,207).